Abstract : The performance of a capacitive and a radiative annular phased array applicator for regional hyperthermia is compared in a model study, for an agar-bone phantom and a structured patient anatomy with a prostate tumour. The capacitive applicator is a model of the Thermotron RF8 device, operating at 8 MHz. Its performance is improved by the use of very cold overlay boli with a suitable salinity. The radiative applicator is a three ring, cavity slot annular array applicator, operating at 150 MHz. The Specific Absorption Rate (SAR) distribution in the cavity slot applicator is optimized by phaseamplitude control. Comparison of both SAR and thermal distributions shows that the radiative applicator can generate good tumour heating in the pelvic region and avoid the overheating of superficial fat layers and muscle tissue seen in the capacitive applicator.
Introduction
The Thermotron RF8 system (Yamamoto VINITA Co., Osaka, Japan) is widely in use in Asian countries for the hyperthermia treatment of tumours. The RF8 system is a capacitive heating device operating at 8 MHz, where the patient is placed between two electrodes which are connected to a high power RF generator 1) 2). The patient is coupled to the electrodes with bolus bags, containing saline water of low temperature. The positive effect of capacitive regional hyperthermia was demonstrated in a randomized study of radiation therapy versus thermoradiotherapy in stage IIIB cervical carcinoma 3).
The basic characteristics of capacitive hyperthermia are related to the E-field orientation perpendicular to the body surface and the low RF frequency 4). These properties result in absorbed power distributions highly governed by tissue anatomy 4). Characteristics are overheating of subcutaneous fat, edge effects effect of regional hyperthermia with radiative applicators, combined with external radiotherapy on pelvic tumours. These early radiative systems are characterized by a deep interference maximum of the absorbed power distribution, but also by treatment limiting local hot spots 16) 17), systemic stress 18) and general discomfort 19) . Egawa et al. 20) compared the performance of the Thermotron RF-8 system with the Annular Array (AA) system 11) in a study with 13 patients with abdominal and pelvic tumours. The study concluded that both systems have advantages and disadvantages, and did not indicate either of the applicators as superior. To resolve these disadvantages, both capacitive and radiative hyperthermia systems became subject of further development and technical improvement.
Recently, hyperthermia treatment planning (HTP) systems have been developed for radiative applicator systems [21] [22] [23] [24] [25] [26] . It has been shown using these HTP's that a new generation of radiative systems can be developed using multiple antenna rings, phase amplitude control and a higher RF frequency 23) 24) 27) 28). The characteristics of a new radiative cavity slot antenna have been described by Kroeze et al. 23) .
Using a quasi static model Kroeze et al. 4 ) developed a HTP system for capacitive regional hyperthermia.
Using both HTP systems, the current paper compares the performance of the RF8 capacitive system with the new design of the cavity slot radiative hyperthermia applicator, using a Japanese patient anatomy with a prostate tumour. The basic performance of both applicator types is investigated in a patient shaped agar-bone phantom, showing the influence of the bone structure on the SAR distribution in the capacitive applicator. The cavity slot radiative applicator is still under study, a prototype has yet to be build. This paper is hence limited to a simulation study.
Methods

Patient model and agar bone phantom
The patient model, Fig. 1 , has been derived from a 40cm CT data set (slice thickness 5mm) of a male, Asian patient with a prostate tumour. All slices in Fig. 1 are displayed centrally through the tumour.
The CT data set was segmented by Hounsfield Unit thresholding 29) and down-scaled to 5mm3 resolution, using the 'winner take all' algorithm 30). This method results in a patient model with regions that are ( 12 ) (1)
SAR optimization
The SAR distribution in the RF8 applicator is optimized with the application of overlay boli and selection of the optimal salinity of both bolus elements (see RF8 SAR model) .
The SAR distribution in the cavity slot applicator is optimized by maximizing the objective function defined as the ratio of total SAR in the tumour versus total SAR in muscle and fat (or in agar in the agar-bone phantom). An optimizer routine modifies the steering vector V in small steps from a start vector in the direction of maximal improvement of the SAR ratio 28) . The optimizer constrains the power per antenna to 10% of the total power in order to avoid an unrealistic power distribution at the antennas. In order to avoid high SAR values in certain subvolumes , these subvolumes can be assigned a weight factor to reduce the local SAR value . In this study a three step optimization technique was employed. In the first step the SAR distribution was optimized for the best ratio of total SAR in the tumour versus total SAR in muscle and fat . In this SAR distribution the volume of the maximal 4th percentile in muscle is determined. This volume is assigned a weight of 10 in the next optimization step. ( 15 ) The effect of this step is a reduction of the SAR maxima in muscle.
The 4th percentile is selected because it generates a volume large enough to have effect in the second optimizing step. In the third step the largest two of the remaining unwanted SAR maxima are manually outlined and assigned an extra weight in the range of 50 to 125, depending on the size of the volume.
SAR distributions can be quantitatively compared using three performance Lidicators, the tumour index (Ti), muscle maximum index (MMi) and the fat maximum index (FMi) 28), defined as : 
(c) (d) heating device operating at 8 MHz, the SAR distribution after three step optimization in the cavity slot applicator operating at 150 MHz is shown in Fig. 2 
(b) and 2 (d). Both sagittal and transversal slices
are taken in the same planes, the slices are taken centrally through the tumour, indicated by the markers in Fig. 2 . The SAR distributions are normalized at a total absorbed power of 700 W in the phantom volume.
The capacitive SAR distribution is characterized by maxima at the edge of the anterior bolus bag and in the constrictions between the bone elements in the pelvic region ( Fig. 2 (a) ). The SAR in the tumor location is relatively low, due to a shielding effect of the pelvic bone. The radiative SAR distribution shows a distinct maximum in the tumor location and minor submaxima anterior to the symphysis os pubica and in the lumbo sacral region. These submaxima were partly suppressed in the three step optimization process. Comparison of the SAR distribution along an anterior-posterior track (dashed 
line in Fig. 1 (c) ) centrally through the tumour (Fig. 3) shows that the SAR in the tumour is exceeded by anterior and posterior peaks in the RF8 applicator. The SAR track in the cavity slot applicator, on the other hand, shows a threefold increase in SAR in the tumour for the same total absorbed power in the patient and an ample reduction of the anterior and posterior peaks with respect to the tumour. This is also expressed in the performance indices (Table III) . 
SAR in patient model
(navel) (Fig. 4 (d) ). These unwanted maxima could not fully be eliminated by increasing the weight of these subvolumina in the objective function without creating new SAR maxima . However, the main SAR maximum is located in the tumour volume.
For a quantitative comparison of the SAR distribution in both applicators, the performance indices are tabulated in Table IV Fig. 1 (c) ). The anterior SAR peak in the RF8 applicator is located in the fat layer, the posterior SAR peak is located in a narrow muscle conduit wedged between two fat volumes . The SAR track in the cavity slot (Fig.  6 (c) ) of the RF8 applicator.
However, the SAR maximum in the thin (1 cm) posterior fat layer did not cause a temperature maximum at the same location ( Fig.  6 (a) 
sweating, thermoesthesia and fatigue, and limit the RF power 42). The SAR maximum in the tumour generated by the radiative applicator allows a significant reduction of the total absorbed power needed to attain the tumour target temperature. This will reduce systemic stress and general discomfort. The unwanted SAR maxima outside the tumour volume cause only minor temperature maxima. The superficial temperature can be maintained low with minor skin cooling.
It has to be noticed, however, that the -results obtained with the radiative applicator are theoretical and depend on the ability to optimize and control the SAR distribution. This implies full phase amplitude control of the system and accurate similarity of the patient position and posture in the applicator with the patient model used in the treatment planning process.
We recently showed that a mere displacement of 2 cm of the patient already causes a deterioration of the performance indices 28).
Seebass et al. 27 ) investigated the influence of amplitude and phase errors at frequencies from 100 MHz to 200 MHz on the temperature distribution and found that this influence decreased with the increase of frequency.
Conclusion
New phase amplitude controlled radiative regional hyperthermia is a good alternative for capacitive techniques in the treatment of tumours in the pelvic region.
The radiative coupling of the patient to the applicator avoids by nature some of the known disadvantages of capacitive systems, such as high superficial heating and thermoesthesia. The large number of degrees of freedom enables the optimizing process to reduce treatment limiting SAR maxima.
Whether these promising theoretical results can be obtained in daily clinical practice depends on progress in the field of phase amplitude control, applicator design and high-resolution hyperthermia treatment planning.
